This blog will explore the fundamental role of biocompatibility testing in medical device development, including the prevention of adverse biological reactions and compliance with ISO 10993 standards. It will cover how early testing and comprehensive documentation accelerate market approvals and reduce the risk of costly recalls, aligning with Eunoia’s personalized consultancy to ensure products meet these critical safety requirements.
Why Biocompatibility Testing is Critical for Patient Safety and Regulatory Success
Read More Post...
ISO 10993-1:2025 Compliance & Biocompatibility – Eunoia Compliance PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993 Is Your Device File Ready for 2025? By Dr. Priyanka Murawala, PhD, DABT, Founder,
PATIENT SAFETY | REGULATORY COMPLIANCE | ISO 10993 Why Biocompatibility Testing Is Critical for Patient Safety and Regulatory Success By Dr. Priyanka Murawala, PhD, DABT, Founder, Eunoia Compliance | 10
This blog will discuss recent trends and changes in regulations for medical devices, highlighting the accelerating approval pathways such as FDA 510(k), PMA, and de novo routes. It will emphasize the importance
Focused on the comprehensive phases of risk management, this blog will break down the essential steps from risk identification and analysis to control and continuous monitoring. It will illustrate how